Citations for
1DENR, EIF2D, MCTS1
Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling.
Skabkin MA, Skabkina OV, Dhote V, Komar AA, Hellen CU, Pestova TV.
Genes Dev 24(16):1787-801. 2010
2MCTS1
Expression and purification of recombinant human MCT-1 oncogene in insect cells.
Pérez-Arellano I, Gozalbo-Rovira R, Martínez AI, Cervera J.
Protein J 29(2):69-74.PMID: 20076993 2010
3MCTS1
Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
Kasiappan R, Shih HJ, Chu KL, Chen WT, Liu HP, Huang SF, Choy CO, Shu CL, Din R, Chu JS, Hsu HL.
Mol Cancer Res 7(4):536-48.PMID: 19372582 2009
4MCTS1
Targeted suppression of MCT-1 attenuates the malignant phenotype through a translational mechanism.
Mazan-Mamczarz K, Hagner P, Dai B, Corl S, Liu Z, Gartenhaus RB.
Leuk Res 33(3):474-82. Epub 2008 Sep 27.PMID: 18824261 2009
5MCTS1, PSIMCT-1
Characterization of the MCT-1 pseudogene: identification and implication of its location in a highly amplified region of chromosome 20.
Nandi S, Shi B, Perreault J, Gartenhaus RB.
Biochim Biophys Acta 1759(5):234-9. Epub 2006 May 22. 2006
6MCTS1
Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter.
Shi B, Levenson V, Gartenhaus RB.
J Cell Biochem 90(1):68-79. 2003
7MCTS1
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.
Shi B, Hsu HL, Evens AM, Gordon LI, Gartenhaus RB.
Blood 102(1):297-302. Epub 2003 Mar 13. 2003
8MCTS1
A novel candidate oncogene, MCT-1, is involved in cell cycle progression.
Prosniak M, Dierov J, Okami K, Tilton B, Jameson B, Sawaya BE, GartenhausRB.
Cancer Res 58(19):4233-7. 1998